GO:0160195 negative regulation of phospholipase C/protein kinase C signal transduction: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0160195 describes any process that stops, prevents or reduces the frequency, rate or extent of phospholipase C/protein kinase C signal transduction.
• The PLC/PKC axis is a central second-messenger pathway: PLC generates diacylglycerol (DAG) and inositol trisphosphate, and DAG recruits and activates PKC isoforms [1, 4].
• Negative regulation of this pathway occurs at multiple nodes, including PKC-mediated feedback phosphorylation of PLC and downstream channels [6, 7].
• Diacylglycerol kinases (DGKs) terminate DAG signals and are keystone negative regulators of PLC/PKC signaling in immune and airway cells [3, 5].
• Dysregulated PLC/PKC signaling contributes to T-cell and B-cell activation defects, asthma pathophysiology, and adipocyte differentiation abnormalities [2, 3, 8].
• CRISPR knockout, point-mutation, knock-in and overexpression models enable causal dissection of negative regulators within this pathway [1, 2, 3].
Description
Phospholipase C (PLC) and protein kinase C (PKC) constitute a canonical signal transduction module that converts receptor engagement into intracellular second messengers [1, 2]. Upon activation, PLC hydrolyzes phosphatidylinositol 4,5-bisphosphate to generate diacylglycerol (DAG) and inositol trisphosphate, and DAG in turn recruits and activates PKC isoforms at membranes. This cascade is essential for lymphocyte activation, adipocyte differentiation, and many other cellular responses [1, 2, 8]. Because unrestrained PLC/PKC signaling can drive pathological activation, cells deploy dedicated negative regulatory mechanisms that stop, prevent or reduce the frequency, rate or extent of this signal transduction. GO:0160195, negative regulation of phospholipase C/protein kinase C signal transduction, captures these braking processes. Understanding this term is important because it defines the molecular checkpoints that keep a powerful second-messenger system under control [3, 6]. Researchers studying immune cell activation, airway disease, and metabolic differentiation increasingly focus on the negative regulators that shape PLC/PKC output [2, 3, 8]. This article integrates the QuickGO definition with verified PubMed literature to provide a research-grade overview of the term, its mechanisms, key genes, disease links, and experimental methods [1, 2, 3, 4, 5, 6, 7, 8].
negative regulation of phospholipase C/protein kinase C signal transduction At A Glance
| GO ID | GO:0160195 |
|---|---|
| GO term | negative regulation of phospholipase C/protein kinase C signal transduction |
| Ontology | biological_process |
| Synonym | negative regulation of PLC/PKC signal transduction |
| Definition | Any process that stops, prevents or reduces the frequency, rate or extent of phospholipase C/protein kinase C signal transduction. |
| Major function | Dampening PLC/PKC second-messenger signaling to prevent excessive cellular activation. |
| Key mediators | PKC isoforms, diacylglycerol kinases, and downstream feedback targets such as TRPC3 [3, 5, 6]. |
| Associated processes | T-cell activation, B-cell activation, adipocyte differentiation, and airway inflammation [1, 2, 3, 8]. |
| Research relevance | Provides a framework for dissecting negative feedback nodes in immune and metabolic signaling [2, 3, 6]. |
What Is GO:0160195?
GO:0160195, negative regulation of phospholipase C/protein kinase C signal transduction, is a biological process term defined as any process that stops, prevents or reduces the frequency, rate or extent of phospholipase C/protein kinase C signal transduction. In practice, this includes feedback phosphorylation events, second-messenger degradation, and other inhibitory inputs that dampen PLC and PKC activity [3, 6, 7].
Why Is negative regulation of phospholipase C/protein kinase C signal transduction Important in Cell Biology?
Negative regulation of PLC/PKC signaling is essential because this pathway is a central amplifier of receptor signals, and its unchecked activity can lead to inappropriate immune activation, airway hyperresponsiveness, or defective differentiation [1, 2, 3, 8]. Defining the negative regulators within GO:0160195 helps researchers identify the molecular brakes that maintain signaling homeostasis and reveals how their loss contributes to disease [3, 6, 7].
• Prevents excessive T-cell activation by limiting DAG-PKC signaling duration [1, 4].
• Controls B-cell activation and differentiation through feedback on PLCgamma pathways.
• Diacylglycerol kinases terminate DAG signals and are keystone regulators in asthma pathophysiology.
• PKC-mediated phosphorylation of TRPC3 provides a direct negative feedback mechanism.
• Regulates adipocyte differentiation by dampening PKC activity.
• Modulates TRPV1 channel activity through DAG metabolism.
• Provides targets for therapeutic intervention in inflammatory and metabolic diseases [3, 8].
• Enables causal gene studies using CRISPR knockout and knock-in models [1, 2, 3].
What Happens During negative regulation of phospholipase C/protein kinase C signal transduction?
Initiation of PLC/PKC signaling
In simple terms: First, receptors turn on PLC, which makes DAG and activates PKC.
Receptor engagement leads to PLC activation and hydrolysis of phosphatidylinositol 4,5-bisphosphate, generating DAG and inositol trisphosphate [1, 2]. DAG then recruits PKC isoforms to membranes, a step required for T lymphocyte activation. This initiating phase sets the stage for subsequent negative regulation [1, 4].
PKC-mediated feedback inhibition
In simple terms: PKC can turn down its own pathway by phosphorylating targets.
PKC activation can feed back to regulate phospholipid hydrolysis and second messenger formation. For example, PKC-mediated phosphorylation of TRPC3 at serine 712 negatively regulates the channel. Such feedback loops are a core mechanism of GO:0160195 [6, 7].
DAG degradation by diacylglycerol kinases
In simple terms: Enzymes called DGKs remove DAG, shutting off PKC recruitment.
Diacylglycerol kinases phosphorylate DAG to phosphatidic acid, thereby terminating DAG-dependent PKC activation [3, 5]. DGK activity is a keystone regulator of signaling relevant to asthma pathophysiology. DGKs also regulate TRPV1 channel activity, illustrating broader roles in sensory signaling.
Negative regulation of PLC-related GTP-binding protein pathways
In simple terms: Some pathways reduce PLC activity linked to specific G-proteins.
Phosphatidylinositol-specific phospholipase C related to pertussis toxin-sensitive GTP-binding proteins can be negatively regulated during adipocyte differentiation. This form of negative regulation of PKC contributes to differentiation control.
Key Genes Involved in GO:0160195 negative regulation of phospholipase C/protein kinase C signal transduction
The following genes and proteins are central to negative regulation of PLC/PKC signal transduction, based on verified literature [1, 2, 3, 4, 5, 6, 7, 8].
| Gene | Major Role | Research Relevance |
|---|---|---|
| PLCG1 | Generates DAG and IP3 to initiate PKC signaling [1, 2] | Target for studying feedback inhibition of T-cell and B-cell activation [1, 2] |
| PRKCQ | PKC theta isoform recruited by DAG during T-cell activation | Key node for negative feedback and immune synapse studies |
| DGK alpha | Phosphorylates DAG to terminate PKC signals | Keystone regulator in asthma pathophysiology |
| DGK zeta | Metabolizes DAG in immune cells | Candidate for modulating PLC/PKC output |
| DGK epsilon | Regulates DAG-dependent signaling | Potential target in inflammatory disease |
| TRPC3 | Calcium channel negatively regulated by PKC phosphorylation | Model for feedback phosphorylation at serine 712 |
| TRPV1 | Sensory channel modulated by DAG metabolism | Links DGK activity to nociception |
| PRKCA | Classical PKC isoform activated by DAG | Studied for feedback on phospholipid hydrolysis |
| PRKCB | PKC isoform involved in second messenger regulation | Relevant to negative feedback mechanisms |
| GNAI1 | Pertussis toxin-sensitive G-protein linked to PLC regulation | Involved in adipocyte differentiation control |
| GNAI2 | G-protein that can modulate PLC activity | Model for negative regulation of PKC |
| PLCB1 | PLC beta isoform coupled to G-proteins | Target for differentiation-related negative regulation |
| PLCG2 | PLC gamma isoform in B cells | Central to B-cell activation and its negative control |
| PIK3CD | PI3K delta intersects with PLCgamma pathways | Co-target for pathway dissection |
| BTK | B-cell kinase upstream of PLCgamma | Relevant to negative regulation of B-cell signaling |
| SYK | Kinase upstream of PLCgamma in B cells | Model for feedback control |
| LAT | Adaptor linking TCR to PLCgamma | Scaffold for negative regulation studies |
| ZAP70 | Kinase required for T-cell PLCgamma activation | Upstream node for feedback analysis |
How Is negative regulation of phospholipase C/protein kinase C signal transduction Regulated?
Negative regulation of PLC/PKC signaling is itself regulated by feedback phosphorylation and lipid second-messenger metabolism [3, 6, 7]. PKC-mediated phosphorylation of targets such as TRPC3 provides direct negative feedback. Diacylglycerol kinases act as keystone regulators by converting DAG to phosphatidic acid, thereby limiting PKC recruitment [3, 5]. In adipocytes, pertussis toxin-sensitive G-protein-linked PLC is negatively regulated during differentiation.
negative regulation of phospholipase C/protein kinase C signal transduction and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| DGK alpha | Asthma pathophysiology | Knockout and overexpression in airway epithelial cells |
| PLCG1 | T-cell activation disorders | CRISPR knockout in Jurkat T cells |
| PRKCQ | T lymphocyte activation | Point-mutation of DAG-binding domain |
| TRPC3 | Calcium signaling dysregulation | Knock-in of phospho-deficient S712A |
| GNAI1 | Adipocyte differentiation defects | Knockout in 3T3-L1 preadipocytes |
Asthma and airway inflammation
Diacylglycerol kinase is a keystone regulator of signaling relevant to the pathophysiology of asthma. Loss of DGK-mediated negative regulation of PLC/PKC signaling may amplify airway inflammation.
Immune activation disorders
Defective negative regulation of PLC/PKC signaling can lead to excessive T-cell and B-cell activation [1, 2]. PLCgamma and PI3K pathways are central to B-cell activation and differentiation, and their dysregulation is linked to immune disorders.
Metabolic and differentiation defects
Negative regulation of PKC is involved in adipocyte differentiation of 3T3-L1 fibroblasts. Perturbation of this regulation may contribute to metabolic disease.
From negative regulation of phospholipase C/protein kinase C signal transduction-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of DGK alpha amplify PLC/PKC signaling? | DGK alpha knockout cell line |
| Is PKC theta DAG binding required for T-cell activation? | PRKCQ point-mutation knock-in |
| Does TRPC3 S712 phosphorylation mediate negative feedback? | TRPC3 S712A knock-in |
| Can PLCgamma negative regulation be tracked in live cells? | Tagged PLCG1 knock-in |
| Does overexpression of DGK zeta suppress PKC output? | DGK zeta overexpression |
| Which G-protein-linked PLC is negatively regulated during differentiation? | GNAI1 knockout in 3T3-L1 |
How to Study the negative regulation of phospholipase C/protein kinase C signal transduction Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Phosphoproteomics | PKC substrate phosphorylation | Identify feedback sites like TRPC3 S712 |
| Live-cell imaging | DAG and PKC translocation | Measure negative regulation kinetics |
| Lipidomics | DAG and phosphatidic acid levels | Assess DGK activity |
| CRISPR knockout screening | Gene requirement for pathway output | Discover negative regulators [1, 2] |
| RNA-seq | Transcriptional changes after perturbation | Profile B-cell activation states |
| Western blot | Protein phosphorylation and expression | Validate PKC feedback |
| Calcium imaging | Intracellular calcium flux | Measure TRPC3 regulation |
| Flow cytometry | Cell activation markers | Quantify T-cell activation |
Phosphoproteomics
Phosphoproteomics can identify PKC-mediated phosphorylation events that negatively regulate PLC/PKC signaling, such as TRPC3 serine 712.
Live-cell imaging of DAG and PKC
Live-cell imaging of DAG and PKC translocation allows real-time measurement of negative regulation, as shown for PKC theta during T lymphocyte activation.
Lipid second-messenger profiling
Mass spectrometry-based lipid profiling quantifies DAG and phosphatidic acid to assess DGK-mediated negative regulation [3, 5].
CRISPR screening
CRISPR library screening can identify negative regulators of PLC/PKC signaling by enriching for sgRNAs that increase pathway output [1, 2].
How CRISPR Can Be Used to Study GO:0160195 negative regulation of phospholipase C/protein kinase C signal transduction
Knockout
CRISPR knockout of DGK alpha or PLCG1 can reveal whether these genes are required for negative regulation of PLC/PKC signaling [1, 2, 3].
Point Mutation
Point mutation of PKC theta DAG-binding residues or TRPC3 serine 712 can test the necessity of specific phosphorylation events in negative feedback [4, 6].
Knock-in
Knock-in of tagged PLCG1 or DGK alleles enables live-cell tracking of negative regulation dynamics [2, 3].
Overexpression
Overexpression of DGK isoforms can suppress DAG-dependent PKC activation and test sufficiency of negative regulation [3, 5].
How EDITGENE Supports negative regulation of phospholipase C/protein kinase C signal transduction Research
Researchers studying negative regulation of phospholipase C/protein kinase C signal transduction-related genes often need to determine whether a candidate gene is causally involved in dampening this pathway or is merely correlated with it [1, 2, 3]. EDITGENE provides the CRISPR tools and bioinformatics support to answer these questions with publication-grade rigor [1, 2, 3, 4, 5, 6, 7, 8].
Contact EDITGENE today to design your custom CRISPR model for negative regulation of phospholipase C/protein kinase C signal transduction research.
Frequently Asked Questions About negative regulation of phospholipase C/protein kinase C signal transduction
What is GO:0160195?
GO:0160195 is the Gene Ontology term for negative regulation of phospholipase C/protein kinase C signal transduction, defined as any process that stops, prevents or reduces the frequency, rate or extent of PLC/PKC signaling.
What genes are involved in negative regulation of PLC/PKC signaling?
Key genes include DGK alpha, DGK zeta, PRKCQ, TRPC3, and GNAI1, based on verified literature [3, 4, 5, 6, 8].
How does PKC negatively regulate its own pathway?
PKC can phosphorylate targets such as TRPC3 at serine 712 to dampen signaling, and it regulates phospholipid hydrolysis and second messenger formation.
What is the role of diacylglycerol kinase in this process?
Diacylglycerol kinases phosphorylate DAG to phosphatidic acid, terminating DAG-dependent PKC activation and acting as keystone regulators [3, 5].
Why is negative regulation of PLC/PKC signaling important in asthma?
DGK is a keystone regulator of signaling relevant to asthma pathophysiology, and its loss may amplify airway inflammation.
Which diseases are linked to defective negative regulation of PLC/PKC signaling?
Asthma, immune activation disorders, and metabolic differentiation defects have been linked to dysregulated PLC/PKC signaling [1, 2, 3, 8].
How can I study negative regulation of PLC/PKC signaling with CRISPR?
CRISPR knockout, point mutation, knock-in, and overexpression models allow causal testing of candidate regulators [1, 2, 3, 4, 6].
What methods measure PLC/PKC pathway output?
Phosphoproteomics, live-cell imaging, lipidomics, and calcium imaging are commonly used [3, 4, 6].
Is TRPV1 regulated by DAG metabolism?
Yes, diacylglycerol kinases regulate TRPV1 channel activity, linking DAG metabolism to sensory signaling.
What is the official synonym for GO:0160195?
The official synonym is negative regulation of PLC/PKC signal transduction.
Conclusion
GO:0160195, negative regulation of phospholipase C/protein kinase C signal transduction, defines the essential braking mechanisms that keep a powerful second-messenger pathway in check. Key mediators include PKC feedback phosphorylation, diacylglycerol kinases, and G-protein-linked PLC regulation [3, 5, 6, 8]. Dysregulation of these processes is linked to asthma, immune disorders, and metabolic defects [1, 2, 3, 8]. CRISPR-based models and multi-omics methods now enable precise dissection of these negative regulatory nodes [1, 2, 3, 4, 5, 6, 7, 8].
References
- 1. Smith-Garvin JE et al.. 2009. T cell activation.. Annu Rev Immunol 27:591-619 PMID: 19132916
- 2. Marshall AJ et al.. 2000. Regulation of B-cell activation and differentiation by the phosphatidylinositol 3-kinase and phospholipase Cgamma pathway.. Immunol Rev 176:30-46 PMID: 11043766
- 3. Hernandez-Lara MA et al.. 2024. Diacylglycerol kinase is a keystone regulator of signaling relevant to the pathophysiology of asthma.. Am J Physiol Lung Cell Mol Physiol 327(1):L3-L18 PMID: 38742284
- 4. Díaz-Flores E et al.. 2003. Membrane translocation of protein kinase Ctheta during T lymphocyte activation requires phospholipase C-gamma-generated diacylglycerol.. J Biol Chem 278(31):29208-15 PMID: 12738795
- 5. Liu L et al.. 2020. Diacylglycerol kinases regulate TRPV1 channel activity.. J Biol Chem 295(24):8174-8185 PMID: 32345612
- 6. Trebak M et al.. 2005. Negative regulation of TRPC3 channels by protein kinase C-mediated phosphorylation of serine 712.. Mol Pharmacol 67(2):558-63 PMID: 15533987
- 7. Bishop WR et al.. 1992. Regulation of phospholipid hydrolysis and second messenger formation by protein kinase C.. Adv Enzyme Regul 32:177-92 PMID: 1323204
- 8. Uehara T et al.. 1994. Possible involvement of phosphatidylinositol-specific phospholipase C related to pertussis toxin-sensitive GTP-binding proteins during adipocyte differentiation of 3T3-L1 fibroblasts: negative regulation of protein kinase C.. Biochim Biophys Acta 1224(2):302-10 PMID: 7981246
